Commercial & ASO

Cut trend. Strengthen the self-funded offering. Give groups a reason to stay.

Dario engagement is a leading indicator of impact, while clinical outcomes validate health improvements and drive downstream cost savings.

Colleagues collaborating around a laptop in an office

What Dario does for Commercial / ASO plans

Trend

Address insured-book cost, led by cardiometabolic conditions and GLP-1 spend

Fees & retention

Give self-funded groups a differentiated clinical offering that can strengthen fee revenue and the renewal conversation

Differentiation

Replace employer point-solution stacks with a configurable platform spanning multiple high-cost needs

See movement inside the plan year

A1c, blood pressure and weight can move before the full claims picture matures. Dario uses these clinical measures as leading indicators while claims analysis validates downstream economic performance.

A hand holding a phone that shows the Dario app home screen

Economic evidence

~$5,077

annual medical-cost savings per member vs. matched non-users1

23.5%

lower inpatient hospitalization rate in a matched claims analysis1,2

9.3%

lower all-cause healthcare utilization in current claims-based evidence3

100+

scientific studies across the evidence base

See the Commercial / ASO opportunity.

Talk with Dario

(1) Sanofi, JMIR 2025.  (2) Dario Clinical Data Overview, July 2026, pp. 21, 22, 26.  (3) Wilson L, et al. J Med Internet Res. 2025;27:e67320. doi:10.2196/67320; Dario Clinical Data Overview, July 2026, pp. 22, 26.